These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 7601686)

  • 1. Comments about vitamins, nutraceuticals, and dietary enzymes.
    Henderson TR
    J Am Vet Med Assoc; 1995 Jul; 207(1):31. PubMed ID: 7601686
    [No Abstract]   [Full Text] [Related]  

  • 2. A precarious balancing act--the role of the FDA as protector of public health and industry wealth.
    McCabe AR
    Suffolk Univ Law Rev; 2003; 36(3):787-819. PubMed ID: 16493844
    [No Abstract]   [Full Text] [Related]  

  • 3. Professional responsibilities.
    Jenkins WL
    J Am Vet Med Assoc; 1993 May; 202(10):1742-3. PubMed ID: 8514601
    [No Abstract]   [Full Text] [Related]  

  • 4. Realizing two-tiered innovation policy through drug regulation.
    Ridgway WE
    Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807
    [No Abstract]   [Full Text] [Related]  

  • 5. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
    Zelenay JL
    Food Drug Law J; 2005; 60(2):261-338. PubMed ID: 16094773
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the pharmaceutical industry in drug development and approval.
    Beleau MH
    Vet Hum Toxicol; 1998; 40 Suppl 2():17-9. PubMed ID: 9823577
    [No Abstract]   [Full Text] [Related]  

  • 7. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

  • 8. Botanical drugs: a future for herbal medicines.
    Li W
    J Contemp Health Law Policy; 2002; 19(1):117-49. PubMed ID: 12733224
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulatory watch: impact of PDUFA on regulatory decision-making.
    Hay M
    Nat Rev Drug Discov; 2010 Aug; 9(8):585. PubMed ID: 20671755
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug safety on trial.
    Nature; 2005 Mar; 434(7033):545. PubMed ID: 15800579
    [No Abstract]   [Full Text] [Related]  

  • 11. Comments about vitamins, nutraceuticals, and dietary enzymes.
    Schmoling GR
    J Am Vet Med Assoc; 1995 Jul; 207(1):30. PubMed ID: 7601684
    [No Abstract]   [Full Text] [Related]  

  • 12. Nutraceuticals: miracle or meme?
    Ridinger MH
    Clin Pharmacol Ther; 2007 Oct; 82(4):352-6. PubMed ID: 17851571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic drugs: the stalling game.
    Consum Rep; 2001 Jul; 66(7):36-40. PubMed ID: 11725791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA user fees and innovation.
    Somberg J
    Am J Ther; 2008; 15(2):97. PubMed ID: 18356626
    [No Abstract]   [Full Text] [Related]  

  • 15. Biogenerics standoff.
    Herrera S
    Nat Biotechnol; 2004 Nov; 22(11):1343-6. PubMed ID: 15529145
    [No Abstract]   [Full Text] [Related]  

  • 16. Vitamins, nutraceuticals, and dietary enzymes.
    Tribby MD
    J Am Vet Med Assoc; 1995 Apr; 206(8):1113-4. PubMed ID: 7768726
    [No Abstract]   [Full Text] [Related]  

  • 17. Remarks at the Food and Drug Law Institute's 48th Annual Conference.
    Niedelman SM
    Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089
    [No Abstract]   [Full Text] [Related]  

  • 18. Separate manufacturing standards needed for veterinary drugs: AVMA.
    J Am Vet Med Assoc; 1996 Feb; 208(4):461. PubMed ID: 8603886
    [No Abstract]   [Full Text] [Related]  

  • 19. Responsible extra-label use of drugs.
    Cobb DV
    J Am Vet Med Assoc; 1996 Nov; 209(9):1545. PubMed ID: 8899012
    [No Abstract]   [Full Text] [Related]  

  • 20. Rising costs hold up drug discovery.
    Miller HI
    Nature; 1998 Oct; 395(6705):835. PubMed ID: 9804407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.